Castle Creek Biosciences buys gene therapy company weeks after canceling IPO plans
January 10, 2022 at 14:55 PM EST
The deal will enable the Exton company to expand both its new product pipeline and its technology platform.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
